INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer's Trial
(NASDAQ: INMB) Delayed: 1.43 -0.02 (1.38%)
Previous Close $1.45    52 Week High $ 
Open $1.41    52 Week Low $ 
Day High $1.48    P/E N/A 
Day Low $1.35    EPS $ 
Volume 284,421       

(NASDAQ: INMB) Delayed: 1.43 -0.02 (1.38%)
Previous Close $1.45    52 Week High $ 
Open $1.41    52 Week Low $ 
Day High $1.48    P/E N/A 
Day Low $1.35    EPS $ 
Volume 284,421